DEVELOPMENT OF RADIATION/NUCLEAR MEDICAL COUNTERMEASURES (MCMS) AND BIODOSIMETRY DEVICES. 7/1/26 - 6/30/27. EO 14271: DAP-NCAP-00000073
$1,492,621
| Recipient | ASELL, LLC UEI ZC5MF9MRE3A5 |
|---|---|
| Award ID | 75N93026C00006 |
| Award amount | $1,492,621 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN12 |
| Set-aside | Unrestricted |
| Start date | Jul 1, 2026 |
| End date | Jun 30, 2027 |
| Place of performance | OWINGS MILLS, MD |
| Record updated | Sep 29, 2026 |
View the official award record
More awards won by ASELL, LLC
ADVANCED DEVELOPMENT, VALIDATION AND FDA CLEARANCE OF THE CELLRADX POINT OF CARE BIODOSIMETRY SYSTEM
Department of Health and Human Services · $10,877,462 · Sep 12, 2022
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids